BREAKING: "Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults"; an excess risk of serious adverse events vaccine over placebo, Doshi et al.
The dam is bursting, the narrative is crumbling: 'Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest'
SOURCE:
‘Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated (95 % CI 2.1 to 22.9); risk ratio 1.43 (95 % CI 1.07 to 1.92).
The Pfizer trial exhibited a 36 % higher risk of serious adverse events in the vaccine group; risk difference 18.0 per 10,000 vaccinated (95 % CI 1.2 to 34.9); risk ratio 1.36 (95 % CI 1.02 to 1.83). The Moderna trial exhibited a 6 % higher risk of serious adverse events in the vaccine group: risk difference 7.1 per 10,000 (95 % CI –23.2 to 37.4); risk ratio 1.06 (95 % CI 0.84 to 1.33). Combined, there was a 16 % higher risk of serious adverse events in mRNA vaccine recipients: risk difference 13.2 (95 % CI −3.2 to 29.6); risk ratio 1.16 (95 % CI 0.97 to 1.39).’
‘The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes.’
0.1% might not sound like much. One in a thousand isn’t something you’re going to notice among your twenty friends who took it. There are many treatments which have over one in a thousand chance of serious outcomes.
However, when we administer this to billions of healthy people, when we coerce its usage, when we don’t have pediatricians warning about side effects, when we don’t do proper safety testing… that’s tantamount to genocide.
A 50% risk is acceptable to the gestapo FDA.